0001958244-24-000011.txt : 20240102 0001958244-24-000011.hdr.sgml : 20240102 20240102171758 ACCESSION NUMBER: 0001958244-24-000011 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Arcus Biosciences, Inc. CENTRAL INDEX KEY: 0001724521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473898435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38419 FILM NUMBER: 24503501 BUSINESS ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 694-6200 MAIL ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Jaen Juan C. CENTRAL INDEX KEY: 0001422996 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 144 1 primary_doc.xml 144 0001422996 XXXXXXXX LIVE 0001724521 Arcus Biosciences, Inc. 001-38419 3928 Point Eden Way Hayward CA 94545 1-510-694-6200 Juan Jaen Officer Class A Common Stock Goldman Sachs & Co. LLC 200 West Street New York NY 10282 100000 1968000 74855565 01/02/2024 NYSE Class A Common Stock 05/08/2015 Acquired from issuer in private transaction The issuer N 100000 05/08/2015 None Y The sales of shares set forth herein are made in connection with a selling plan dated 08-Aug-2023 that is intended to comply with Rule 10b5-1(c). 01/02/2024 08/08/2023 Goldman Sachs & Co. LLC on behalf of Juan Jaen